Goodwin Biotechnology, Inc

Goodwin Biotechnology, Inc. (GBI) is a fully integrated GMP contract manufacturer of mammalian cell products providing process development (upstream and downstream) and cell banking through production, purification, and sterile fill. The downstream 

The strategy is to expand both laterally and horizontally through acquisition of proprietary process technology and expansion and scale up of manufacturing capabilities. Expansion strategy is being executed in two phases (1) addition of reactors in the pilot facility and (2) construction of a facility for manufacture of Phase III/BLA products. 

---